Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We should be $3+ based on the potential. But, as we all know, Lightwave has consistently not delivered for far too long. That, as well as the lack of effort to create awareness, has us at $1. Personally, I think it was Walter's promo that brought in the heavy buying and not a rise from upcoming news. As each day passes quietly I believe that more and more. If I remember correctly at the SHM Tom said it would take 2 months for the testing facility to be fully operational. So that's pretty much today. If that is what the next PR is about I'll add it to the list of PR's that won't move the stock, it is not "new" news.
Buz, this is for you.
For those who follow Hochberg.
http://www.udel.edu/udaily/2013/oct/hochberg-photonics-101712.html
RJ we'll need screen shots to verify that top secret info wasn't posted, LOL. Two months after the SHM the members here are craving information and updates like zombies do brains and flesh. Another month of silence and Zelibor could be getting chased down like 1931 Frankenstein.
What was it about?
Speaking of old articles, check this one out, it was new to me. I didn't realize until now that his day job is at Harbor View Capital Management. No wonder he is too busy to answer Lightwave emails.
http://seekingalpha.com/article/221714-lightwave-logic-ushering-in-a-new-era-of-data-communications
Sorry about post #588. I mixed my browser tabs up.
Last week I was at the home of a gentleman who retired early after a mishap at his job caused him to suffer mostly 2nd and some 3rd degree burns on nearly 90% of his body. He was very comfortable talking about what happened to him and in gruesome detail went on about the skin grafting, silver sulfadiazine, and the recovery process. It was a horrible experience. Later on I asked if he had heard of Avita Medical, he had not. I wrote down Avita Medical Re-Cell and told him to Google/YouTube it later on and then let me know what he thought about it. I told him it was a public company that I invested in and I would value his opinion. I was hesitant to do this though. After hearing about everything he went through with his burns I thought it might upset him to know that there was a better way out there but it just wasn't available in the U.S.
That night my new friend read all about Re-Cell, watched all the videos ect. He was extremely impressed with Re-Cell. The next morning he said he called his portfolio manager. The manager said that AVMXY isn't the kind of stock they suggest but that they had never heard of it though it sounded promising. Coincidentally, that same day 22,000+ shares of AVMXY were purchased. 10 times what goes through on a normal day.
Avita Strengthens Board
Australia, 19 October 2012— Regenerative medicine company Avita Medical Ltd. (ASX: AVH), (OTC:
AVMXF), (OTCQX:AVMXY) announced that further to ASX announcements on 5 September 2012 and
16 October 2012 and following today’s Shareholder Meeting it is pleased to announce the
appointments of Jeremy Curnock Cook and Matt McNamara to the board of Avita Medical. The
strengthening of Avita’s board follows the company’s successful capital raising of A$10.3m.
Avita Medical’s Chairman, Dalton Gooding stated the appointments of Mr Curnock Cook and Mr
McNamara further strengthen Avita’s board.
“I am delighted that both Jeremy and Matt have been appointed as directors of Avita Medical and I
extend a warm welcome on behalf of the board,” Mr Gooding said.
“We look forward to drawing on the extensive experience that both Jeremy and Matt have in
Biotechnology and Healthcare as we continue to increase our ReCell
®
Spray-On Skin
®
sales.”
Mr Curnock Cook is currently on a number of boards of International Healthcare and Biotechnology
companies. Jeremy is the former head of the life science private equity team at Rothschild Asset
Management, was responsible for the launch of the first dedicated biotechnology fund for the
Australian market and the launch of a joint venture with Johnson & Johnson Development
Corporation for the creation of Healthcare Ventures, an investment vehicle dedicated to seed stage
investments in Europe, as well as the conception and launch of the International Biotechnology
Trust (IBT).
Mr McNamara is currently the Chief Investment Officer and Fund Manager of Octa Phillip
Bioscience Managers. Matt has over 23 years experience in the Healthcare & Medical Sciences
sector. After initially being a Molecular Biology Research Assistant, Matt spent 11 years in Sales &
Marketing, and General Management with Merck & Co. and Johnson and Johnson Medical Pty. Ltd.
respectively. He has served as SVP Business Development for a University of Sydney spin out,
eBioinformatics Inc. and was CEO of a Life Sciences Venture Capital fund, SciCapital Pty. Ltd.
The board would also like to thank Dr Paul Watt who has retired from the board of Avita Medical
effective immediately. The board would like to acknowledge Dr Watt’s extensive contribution that
he has made over a 10 year period including 6 years as a director of pre-merger company Visiomed
Limited. Dalton Gooding stated, “The board wishes Dr Watt all the very best and success with his
future endeavours.”
http://member.afraccess.com/media?id=CMN://6A609022&filename=20121019/AVH_01345391.pdf
Tisk tisk Snez. Nebraska is a EXTREMELY friendly mining state, another plus for Quantum. If Molycorp is doubling production at Mountain Pass in California I think we can dig some holes in a town in Nebraska with a population of 115. The locals have probably already killed all the rare wildlife than might interfere with them getting paid royalties lol.
By the way Snez, could you email me. I want to ask you a question about Petromanas. inversor86@yahoo.com
There was a lot of buying a few weeks ago. While there is no buying pressure now there is also no selling pressure. This stock is way off the radar and the only people who even are aware we're close to a deal already are invested and probably in the red. Everyone bought it assuming good odds of success in 2012. The nearing of a deal isn't a catalyst for new purchases from longs, that's what got us here to begin with. Now if the CEO says something about how they're reviewing offers then I'd expect some action. Right now I take buying as a sign that a nice offer(s) came in, selling that they didn't, and neither as everyone waiting.
The suspense is killing me.
Could you send it to me? inversor86@yahoo.com I wasn't here at that point last year.
I took it down. In that Pro Active Investor interview Dickie says 1-2 months is when he expects a deal would be complete. So there's the timeline I wanted. Actually, that was almost 2 weeks ago so deduct that time. The way the stock is not moving I'd say nothing has come in yet.
Where did you see the ASM from 2011? Saved on your computer?
If Steve writes PRs as slow as he replies to my emails we may never have news again. I haven't been able to get a reply since August.
Money News Today reposted the Pro Active Investor article.
http://moneynewstoday.co.uk/quantum-rare-earth-developments/
Good video to watch for anyone who wants to get a grasp on how pbt2 works.
I sent that SA author some info about Quantum, hopefully he feels that a write up about us nearing a deal with a strategic partner would be worth the time. :)
Sixshot is aggies or one of the ymb tools trying to fly under the radar. Sorry, just calling this like I see it. Read all his posts, they are always passively negative, he only posts on the LWLG board, nearly half of his posts have come since LWLG started to go on a short run this week. It all seems too coincidental.
I was thinking about the same thing today. Here's how I see it. The stock was starting to move up before Walters piece but no doubt that was the reason for most of the movement today. However, Walter is bringing something that is needed, new blood. I've learned in the year I've been into this that many of shareholders have been here for years. That's not good, you don't want a excessive amount of investors who are already over saturated with stock. You will have a numbness to positive developments without people fresh into this who see that as a reason to add to their position. I say let Walter tell the world, they are buying because they see value here and that is positive.
Translated Walter's PR :)
Probably not perfect but you'll get the idea.
The Option Specialist: LWLG Investment of the Future!
The Option Specialist : Share of the Future LWLG. Below is a contribution of the Option Specialist Leon van Dam. No, this acronym stands for Lone Wolf Long Will not ... but for Lightwave Logic.
LWLG Lightwave Logic
Important: this is not a vision or recommendation of Option Academy! It is a speculative speculation and you would like a long option can see from less than $ 1. A kind of scratch card so ... Nevertheless, we want the following contribution Leon can not remember. As already indicated last Saturday if you love me (Leon van Dam, ed) have analyzed a very promising mi share with confidence.
Disclaimer:
As always, there is never 100 percent guarantee of success. This is in my opinion a promising share and I myself have a fairly large position. Garnish with money that you absolutely can not miss: no bread to eat less when the entire investment could fall into the water!
The Option Specialist : Lightwave Logic Investment of the Future!
Introduction
On the Internet we are, in the not so distant future, with the same problem as us traffic: the Internet affected by the accumulated fixed. Moore's Law begins to falter. ( http://nl.wikipedia.org/wiki/Wet_van_Moore ) Silicon and copper have almost reached their limits and the demand for capacity is growing. Now, the products of Lightwave Logic (LWLG) provide the solution.
Dr.. Frederick Goetz, founder of LWLG, got together for what several Fortune top hundred companies failed and through a new material: Perkin Amine chromophore, with very high electro-optical characteristics.
For a rough idea of ??what it handles: replace electrons by photons and silicon and copper by plastic and thinking of a future optical computers (faster, cheaper, less energy consumption) and you will understand that there is serious potential.
It gets even more interesting when we take a look at which products store on the pipeline and in which markets. Why operates this business for years under the radar, though some already talking about the Holy Grail?
LWLG is currently still in development, but is rapidly evolving into the commercial phase: the next six months are crucial. I just put it all out below:
Products and markets
The Chip Market
For two years, a Fortune 100 company (micro-electronics company) the material of Lightwave Logic studying to use in an optical communication system. The name of the top 100 business should not be disclosed because of the current non-disclosure agreements. In the first phase will be developed hybrid products such as potato chips and a video LWLG material is attached, and then later switch to chips completely Perkin Amine.
Defense
In military applications thinks of smart weapons. One of the problems in the wars in Iraq and Afghanistan, the number of American deaths and injuries which are due to friendly fire. Smart weapons based on Lightwave Logic material would solve this problem immediately.
Other markets
End of 2012 there will be a first prototype of a spatial modulator ready to be steamed under the leadership of Terry Turpin (optical guru) based on LWLG material. ( http://en.wikipedia.org/wiki/Spatial_light_modulator )
The images would be a billion times faster (!) Than previous systems http://finance.yahoo.com/news/Lightwave-Logic-Terry-Turpin-prnews-1963996603.html?x=0 ; causing facial recognition and autonomous cars become reality: this would include use of go in cameras fight against terrorists, but also in air raids in enemy territories.
Telecom
Under the direction of Fred Leonberger, former CTO of JDS Uniphase, develops LWLG a "Mach-Zehnder modulator based" on the basis of Indigo, the lithium niobate based modulator must forget.
This modulator, the growth in IP traffic support: Mobile data traffic by 2015 will double each year, the portion web videos ever increases. Current technology may soon be no more.
Space
Optical limiters are used in satellites to avoid satellites disabled through strong lasers.
Medical science
LWLG has signed a contract with Fiber Logix for building biomedical sensors and sensors for detecting infections in the body, including in the field of medical diagnostics is a billion dollar market open.
Energy
And what do the subsidy that the University of Alabama has received and which investigates how efficient Perkin Amine absorbs sunlight which may be converted into another form, so that this energy can also be stored in such liquid state.
Obviously, the discovered materials protected by patents; LWLG has 6 patent applications of which the two most important now been approved. Also regularly patents at.
Financing
Most companies fail in development due to lack of cash. LWLG has a funding agreement with Lincoln Partners regularly and on demand shares should decrease to a maximum of 20 million dollars. (With an average market price determined by a formula but only if the market price is above $ 1.00). The company has no debt and the interests of management are similar to those of shareholders, because their fees primarily consist of options and warrants.
Management and Board of Directors
The reader will already quite a few times have shaken his head at the grand plans and capabilities that were outlined above. However, you are going to seriously look at them if you know what an impressive management team in this small business operates. http://www.lightwavelogic.com/about_us_leadership.html I confine myself to a few additions at the end of 2011.
Joe Miller is VP and CTO of Corning Incorporated and was responsible for the new strategy this company so successful maakte.Wellicht says the name of the company you are little, but you know the products of this company no longer: you move your fingers over daily the glass of your smartphone. Made by Corning. He is now an independent director at LWLG. Lou Glasgow worked with him at Corning and Glasgow is now CTO at LWLG.
The latest addition in 2011, the modulator husband, Fred Leonberger was CTO at JDU Uniphase and arrives at LWLG as advisor brought the market price of the share equally above the $ 3.00 (In December it was still $ 0.60).
Add to that some names of people who have been working for LWLG and it is clear that we are not just dealing with what entepreneurs: Dave Eaton, Terry Turpin, Admiral Zelibor, Ross Fasick. William Picket, Chuck Olson etc ....
Upon further reading of their CV s shows that the core of management is very similar to an old boys club of Dupont de Nemours: together they were previously responsible for numerous patents.
Cooperation with universities
LWLG worked with three universities: the University of Alabama) that the complex chemical problem solving), the University of Colorado (with expertise in engineering and design) and finally City University of New York (Cuny) (Labaratory for micro and nano photonics.
Recently LWLG itself a new laboratory in use so they can test themselves targeted, making them faster to commercial applications may come. In addition, a number of researchers from these universities acquired.
http://finance.yahoo.com/news/lightwave-logic-strengthens-research-development-170000366.html
http://finance.yahoo.com/news/babu-g-sundar-ph-d-140000907.html
General Meeting of 24 August 2012
http://www.lightwavelogic.com/
See the video below
For a shareholder is listening to the video of the meeting is a must. At this meeting, led by Admiral Zelibor, the new strategy explained. LWLG is not just material invent, produce and collect royalties, but also strategic alliances and even M & A contract, so that in the very near future all earnings will go to acquire.
It is expected that in the next weeks first acquisition will be achieved with a small dilution of the shares will cause.
Try Googling on: Admiral Zelibor. His motto is: under promise and over deliver.
Challenges
LWLG has in store different materials with different characteristics which Indigo is the most spectacular. http://www.lightwavelogic.com/technology.html : The science is done, but now it comes to the materials repeatedly to reproduce exactly the same characteristics, so a consistency in the production to achieve.
A world expert in this field, Professor Alan Michelson, will have to solve for them: at the meeting said: this is not a question of if but when.
http://ecee.colorado.edu/fac_staff/personnel_pages/mickelson.html
General summary and assessment: Is this share decent buy?
We can use a number of reasons why institutional investors that share not massively bought. LWLG is currently traded on the OTC market and that market is seen as somewhat unreliable. The company is still in a development phase and the question is how long it takes before the products are operational, etc. etc.
Making predictions is always dangerous, but we can not escape entirely to the judge or shares are worth buying.
Initially there will be a place acquisition of a strategic partner with perhaps a small dilution effect. I think this is more likely to increase than to decrease lead, but honestly that conjecture.
However, when the consistency problem is solved and a joint development contract would come with a Fortune top hundred business, the Sky is the limit!
Writer of this article believes that there is then a so-called bidding war can come between a few large companies to LWLG to take over because of the huge potential. We talk about many billions in sales in different markets. This is a club of mature managers. If you are over 65 you're not yet 10 years of business further roll. To use the words of one of them to say: We are to old to keep green bananas. A sales price under $ 10.00 would be very disappointing for them.
So now Buy?
For those who want to take a risk, this is a nice time to buy, the price is still below $ 1.00. A long-term call on any share costs even more.
Investors that minimizes risk to take better wait for the results of the tests, with the risk to miss the first battle.
If you are not convinced: Admiral Zelibor, Joe Miller, Fred Leonberger and Lou Glasgow have not committed the autumn of their career in this business to fail.
No cure, no pay!
LWLG has the most impressive management team on the OTCB (according to a shareholder at the meeting this IBM would be jealous) and the management will only pay if the proportion is rising: No cure, no pay!
Symbol: LWLG
Security code: 128778
ISIN: US5322751042
Last Price: USD 0.89
Sincerely,
Leon van Dam
www.optiespecialist.com
Writer has a position in the share LWLG and the subscribers of Lone Wolf Specialist Option Trader.
PS: If you are following this newsletter a (trial) subscription to decrease I refer you to the site: www.optiespecialist.com
Direct contact: leonvandam@ziggo.nl and / or lvandamnl@yahoo.com
Share of the future: Lightwave Logic!
The asks keep getting taken out. I'd be happy with .98
Edit: Damn, it literally hit $1 while was posting!
I'm enjoying the show. I also enjoy seeing people live on here. I am concerned about what someone posted about the DEA holding this up because of Wall Street Lobbyists. I hadn't thought of that possibility.
I don't expect one, and I wouldn't be worrying about one now. From the shareholders meeting I was under the impression that Lightwave will bring the share price to a NASDAQ level on its own merit. If they can't do that then this stock isn't worth keeping anyway.
I sent the authors an email. Maybe I can get some more info. 3 government contracts, Christmas coming early for us? Doubtful.
Good find by the way sixshot
Dr. Fiona Wood doesn't come up very often but she is the one who invented the spray on skin that makes up Re-Cell. She is very talented, however as a shareholder I'm glad she is not running Avita. I think she would turn us into a nonprofit in an effort to help as many people as possible. Not to knock that good hearted thinking, but it's always difficult for an investor when they get into a company with great technology only for it to be almost given away for the "greater good." That's why I like the current CEO Dr. Dolphin. He has a record of coming in, getting profitable, and selling the company.
Fiona Wood's burn therapy spreads to the world.
http://m.perthnow.com.au/news/breaking-news/fiona-woods-burn-therapy-spreads-to-world/story-e6frg13c-1226490926227
by: Rebecca Le May From: AAP October 08, 2012 4:40PM
RENOWNED burns specialist Fiona Wood says her ground-breaking spray-on skin treatment is close to a "tipping point" for widespread use around the world.
Dr Wood's ReCell spray-on skin treatment involves using a patient's own cells in a regenerative process, eliminating tissue rejection, speeding up healing, minimising scars and reintroducing pigmentation to the skin.
The therapy helped many of the 2002 Bali bombing survivors, but commercialising it through stock-exchange listed Clinical Cell Culture Ltd, now named Avita Medical, has proved a hard slog.
The company had spent years trying to get ReCell past complex US Food and Drug Administration hurdles, but progress was being made, and it was increasingly being used in Europe, Dr Wood said.
"I was privileged in going to Rome to the first ReCell users meeting, and for me it was just fascinating that ten years on from the establishment of Clinical Cell Culture, the technique was being used by many other surgeons, now in the hundreds," the 2005 Australian of the Year told AAP.
Advertisement
"It's been a long road and it's been very hard.
"We're getting close to that tipping point where it will be part of not just a few surgeons' toolbox, it will be much more commonplace."
The plan was to commercialise ReCell to fund further burns research, and royalties were starting to trickle through, she said.
"That was a bit of a naive plan and it was much harder than we expected.
"But we're slowly getting there.
"For us, it was never about personal gain, it was to maintain that work."
Dr Wood says there has been a leap in our preparedness to deal with disasters like the 2002 Bali bombings, which claimed the lives of 202 people including 88 Australians.
The Australia and New Zealand Burns Association has worked with health departments throughout the country on disaster planning, and those efforts had been refined and formed a template for the National Trauma Disaster Plan.
That plan was tested in 2009 with the Ashmore Reef asylum seeker boat explosion, Dr Wood said.
The acclaimed surgeon said research on the long-term outcomes of burns treatments had also come a long way.
"Every intervention you do, you have to be able to measure the impact," she said.
"That is not easy in such a multifaceted area of pathology because burns affect all body systems, so we have to understand the effect on the liver, the heart, the brain, the lungs, the musculoskeletal system, et cetera.
"Understanding the mechanisms of these changes was really important.
"That was an enormous step forward.
"Our mantra is 'the quality of the outcome must be worth the pain of survival'."
Dr Wood, who has also treated the ultramarathon runners burned in a 2011 Kimberley bushfire, said the battle to overcome psychological scars from burns also could not be underestimated.
"Even a small scar can really rattle your wheels."
There was still a long way to go towards the goal of "scarless healing", but her journey has so far been very rewarding.
"I am surprised and inspired by the resilience of human spirit," Dr Wood said.
Hey snez, so you're in on this Quantum action too? It's turned into the Lightwave hedge.
In a phone interview this week, Peter Dickie of Quantum Rare Earth Development said he hopes to have proposals from companies interested in developing the mine “in the next few weeks.”
Looks like the potential for a partnership in a couple months is looking pretty good! It sounds like more than just a couple proposals are coming in. That's a great interview to read before starting the weekend.
But the banks will be closed Monday. So transfer all your money to buy Lightwave with today.
I don't have a problem with .125 I assume they didn't work this deal out in the past week, when the stock finally got above .125 Pretty much from Mid may to September .125 was the avg. That's actually my cost basis. From my experience with other stocks that have done private placements they usually are annoyingly lower than the normal share price (35-40%). When I first started to read the article I automatically thought "I hope it's above .10 a share."
I agree. It gives them an edge negotiating and that is what's best for us. Since the management doesn't get a salary a half million should last pretty long if it has to.
I'd like to know who the shares are going to.
I posted a link to it.
http://www.marketwire.com/press-release/Quantum-Announces-Private-Placement-TSX%20VENTURE-QRE-1709702.htm
Saw it on twitter.
Running out of operating capital won't be a concern now.
I choked on my drink when I read the Honey Boo Boo comment. In this country if that happens were at $50 instantly.
Avita scores $880,000 in addition funding.
There was some good news out at the end of last week. Article Below or read it here
September 28, 2012 13:05 ET
Avita Medical Secures Additional Funding From US Department of Defense
Awarded Additional $880K in Support of Pivotal FDA Trial; Strong Endorsement Reflects AFIRM's Confidence in ReCell Technology
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM--(Marketwire - Sep 28, 2012) - Regenerative medicine company Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY) announced that it has been awarded a grant of an additional US$880K in support for its on-going pivotal US FDA trial for the use of ReCell® Spray-On-Skin® in the treatment of burn injuries.
The award, supplementing the $1.75 million provided in prior funding, underscores the commitment by the US Department of Defense, the US Army, and the US Armed Force Institute for Regenerative Medicine (AFIRM) to bringing the 'revolutionary' ReCell technology through the FDA approval process and cleared for sales in the US, thereby having it available for the military and civilian population.
The AFIRM program, established in March 2008, is dedicated to bringing 'transformational technologies' in regenerative medicine to wounded soldiers by developing clinical therapies and advanced treatment options. AFIRM has a special interest in using the most advanced regenerative medicine for its wounded soldiers and recognises Avita's innovative treatment for burns and other skin injuries has the benefits of using the patient's own skin, yields improved healing, reduced scar formation, and reintroduction of pigmentation into the skin.
As a first of its kind, the FDA-approved study is rigorous and highly conservative in its design. Each patient in the study receives both the standard-of-care graft treatment and the new ReCell treatment consisting of sprayed autologous cell suspension, with a host of separate assessments beyond standard care required for each enrolled patient. The study design requires similarity across patients, and, within patients, two comparable wounds for treatment, which although necessary for a randomized controlled clinical trial, imposes tight inclusion and exclusion criteria and therefore constrains the use to a particular (and small) subset of burn patients.
The approved FDA protocol permits the Company to treat 106 patients with partial-thickness thermal injuries; patients are assessed for healing and pain on a weekly basis during the initial four weeks post-treatment; at weeks 8, 12, 16, 24 and 52 the treatment site will be assessed for healing and aesthetic outcomes. Clinical data at the 16 week follow-up will be reported to the FDA in support of an application to market ReCell in the US. Approximately 75% of the required subjects have been enrolled in the study.
"We are pleased and grateful for the continued support of the US Department of Defense and AFIRM program," said Dr William Dolphin, Avita Medical's CEO. "As a first-of-its-kind study the patient selection criteria and protocol for the FDA study are stringent, requiring significant commitment from the participating surgeon and their team. AFIRM has recognized the difficulty of the protocol -- reflected in the slower than hoped for enrollment -- and, following close scrutiny and careful review, have provided additional funding in support of the study -- further indication of the importance of this innovative technology. ReCell has shown the potential to provide significant benefits over current options in the treatment of burns and other acute and chronic wounds and for a wide range of skin defects."
Dr James H. Holmes IV, Director of the Wake Forest Baptist Medical Burn Center and Program Leader for the Wake Forest-Pittsburgh Consortium of AFIRM, said, "AFIRM views the ReCell FDA study as a high priority project and recognizes ReCell as a potential game-changer in the treatment of burns and acute wounds. The AFIRM program managers have acknowledged that this is an extremely difficult study and are backing their assessment of the importance of the ReCell technology with additional funding at a time of tight budgetary constraints."
About Avita Medical Ltd.
Avita Medical (http://www.avitamedical.com/) develops and distributes regenerative and tissue-engineered products for the treatment of a broad range of wounds, scars and skin defects. Avita's patented and proprietary tissue-culture, collection and application technology provides innovative treatment solutions derived from a patient's own skin. The company's lead product, ReCell® Spray-On Skin™, is used in a wide variety of burns, plastic, reconstructive and cosmetic procedures. ReCell is patented, CE-marked for Europe, TGA-registered in Australia, and SFDA-cleared in China. ReCell is on market and generating early revenues. ReCell is not available for sale in the United States; in the U.S. ReCell is an investigational device limited by federal law to investigational use. A Phase III FDA trial is in process.
About Avita
The Armed Forces Institute of Regenerative Medicine (AFIRM, www.afirm.mil) is a six-way partnership among the U.S. Army, Navy, and Air Force, the Veterans Health Administration, the Defense Health Program, and the National Institutes of Health. The US Department of Defense established the AFIRM in 2008 with the mission of developing new products and therapies to treat severe injuries suffered by U.S. service members.
65000 @.15. I haven't seen the bid that large the since I got into this stock 5 or so months ago. Hopefully this is a good sign.
The computers are probably going haywire again.
Cliffs: X says Google electro optic polymers and go to the 4th link down. I saw it and posted about it, not long after the page ceases to exist.
X printed it out so if he has a scanner it won't be too difficult to put up. Or email it to me and I'll host it.